The First Hospital of Jilin University: clinical-trial pipeline
The First Hospital of Jilin University is the sponsor of 182 clinical trials in ClinicalTrials.gov and the EU CTIS portal; 73 are not yet finished and 6 were first posted in the last 90 days. Source: Arcadium Data, data as of .
Trials by phase
| Phase | Trials |
|---|---|
| Not applicable | 130 |
| Phase 2 | 26 |
| Phase 4 | 11 |
| Phase 1 | 5 |
| Phase 1/2 | 4 |
| Early phase 1 | 2 |
| Phase 2/3 | 2 |
| Phase 3 | 2 |
Trials by status
| Status | Trials |
|---|---|
| Unknown | 64 |
| Completed | 43 |
| Not yet recruiting | 34 |
| Recruiting | 34 |
| Active, not recruiting | 5 |
| Terminated | 1 |
| Withdrawn or not authorised | 1 |
Condition areas
| Area | Trials |
|---|---|
| Oncology | 86 |
| Gastroenterology and liver | 28 |
| Infectious disease and vaccines | 15 |
| Neurology | 11 |
| Women's health and obstetrics | 11 |
| Nephrology and urology | 9 |
| Cardiovascular | 8 |
| Immunology and rheumatology | 8 |
| Metabolic and endocrine (diabetes, obesity) | 6 |
| Respiratory | 6 |
| Musculoskeletal | 5 |
| Psychiatry and mental health | 4 |
Countries
| Country | Trials |
|---|---|
| China | 131 |
Latest changes
| Day | Change | Trial |
|---|---|---|
| 2026-10-19 | New trial posted | Intranasal Dexmedetomidine Combined With Esketamine for Emergence Quality After Suspensio… |
| 2026-09-28 | New trial posted | Safety and Analgesic Efficacy of the Biased μ-Opioid Receptor Agonist Tegileridine for Po… |
| 2026-09-28 | New trial posted | JLU_Nutr_FI Registry: A Prospective Registry of Feeding Intolerance in Critically Ill Pat… |
| 2026-09-11 | New trial posted | Efficacy Evaluation of Microwave Ablation Assisted by Diaphragm Hydrodissection for Hepat… |
| 2026-09-08 | New trial posted | Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or… |
| 2026-08-27 | New trial posted | Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophag… |
Open trials
The 25 most recently changed open trials.
| Registry id | Title | Phase | Status | Countries |
|---|---|---|---|---|
| NCT07374393 | Establishment of a Sleep and Sleep-disorder Research Cohort in Patients With Neurological Disorders | Not applicable | Recruiting | China |
| NCT07748481 | Comparison of the Therapeutic Efficacy of Non-touch Microwave Ablation, Tumor-puncture Microwave Ablation and… | Not applicable | Not yet recruiting | |
| NCT07806110 | Gemcitabine and Albumin-Bound Paclitaxel Combined With Liposomal Irenotecan (II) With or Without SHR-1701 as… | Phase 2 | Active, not recruiting | China |
| NCT07296393 | Vitamin A in Cord Blood and Preterm Outcomes | Not applicable | Not yet recruiting | |
| NCT07400302 | Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery | Phase 2 | Recruiting | China |
| NCT06525714 | Effect of HIPEC After Radical Surgery on Long-term Survival for Locally Advanced Gastric Cancer | Early phase 1 | Not yet recruiting | |
| NCT06105203 | RATME Vs LATME in Middle and Low Rectal Cancer | Not applicable | Not yet recruiting | China |
| NCT06990334 | Application of Transcriptome Sequencing Combined With Family-Based Whole Genome Sequencing in Improving Preci… | Not applicable | Not yet recruiting | |
| NCT06740955 | Hypofractionated Radiotherapy | Not applicable | Recruiting | China |
| NCT05784974 | Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung Cancer | Phase 2 | Not yet recruiting | |
| NCT06595342 | A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China | Not applicable | Not yet recruiting | China |
| NCT06315270 | To Explore the Feasibility of Dynamic Changes of TCR Diversity in Peripheral Blood in Monitoring Recurrence a… | Not applicable | Not yet recruiting | |
| NCT07790809 | Safety and Short-term Outcomes of Modular Robotic System for Siewert II/III Gastroesophageal Junction Cancer | Not applicable | Recruiting | China |
| NCT06982872 | Comparison of the Diagnostic Performance of Different Artificial Intelligence Assisted Endocytoscopy for Colo… | Not applicable | Recruiting | China |
| NCT07440368 | Enterocyte Injury and Acute Gastrointestinal Dysfunction in Critical Illness | Not applicable | Not yet recruiting | |
| NCT06994312 | The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing He… | Not applicable | Not yet recruiting | |
| NCT06574412 | Cardenilimab Combined With Lenvatinib in Patients With Perioperative Resectable Clear Cell Renal Cell Carcino… | Phase 2 | Not yet recruiting | |
| NCT07559760 | New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer | Phase 2 | Recruiting | China |
| NCT07495384 | Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Sin… | Not applicable | Recruiting | China |
| NCT07439991 | Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery | Not applicable | Recruiting | China |
| NCT06868017 | Randomized Controlled Clinical Study of Efficacy and Safety of Initumab Combined with Pyrrotinib and Chemothe… | Phase 4 | Not yet recruiting | |
| NCT06875076 | Multicenter Single-Arm Study of Ivonescimab (AK112) Combined with Chemotherapy in Pretreated Pleural Mesothel… | Phase 2 | Recruiting | China |
| NCT04326153 | Neoadjuvant Immunotherapy Plus Chemotherapy for Potentially Resectable Stage IIIA/IIIB Non-Small Cell Lung Ca… | Phase 2 | Active, not recruiting | China |
| NCT07493824 | Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment o… | Phase 4 | Recruiting | China |
| NCT06914661 | Efficacy and Safety of DS8201 in Metastatic Breast Cancer's Treatment | Not applicable | Recruiting | China |
All sponsors: clinical-trial pipeline by sponsor.
Track a sponsor's pipeline
The API returns the same trials by sponsor website, phase, status, condition and country with a change feed, joined to hiring and public contract awards. Try it without a key on one sponsor.
Sources: ClinicalTrials.gov (U.S. National Library of Medicine, public domain) and the EU Clinical Trials Information System public portal (European Medicines Agency), data as of 2026-10-25. A trial that one register cites in the other is shown once. Organisation-level data only: investigators, contact persons and site names are not stored, and a sponsor that could be a private person is withheld. Sponsor-to-website matches are made by name and can be wrong; check the register before relying on a record. Independent of the NLM, NIH and EMA.
Cite as: Arcadium Data, "The First Hospital of Jilin University clinical trials: 73 open, 4 in phase 3", https://arcadiumdata.io/clinical-trials/sponsor/the-first-hospital-of-jilin-university/, data as of 2026-10-25.